Advanced Skin Cancer: What Happens After Diagnosis?

What happens when a skin cancer diagnosis goes beyond the dermatologist's office?In this episode of Skinside Out, Dr. Zain Husain is joined by two leading medical oncologists to discuss advanced squamous cell carcinoma, melanoma, immunotherapy, clinical trials, and the future of cancer treatment. The conversation explores how dermatologists, surgeons, radiation oncologists, and medical oncologists work together to create personalized treatment plans for patients with complex skin cancers.The team explains how melanoma spreads, the role of sentinel lymph node biopsies, why immunotherapy has transformed cancer care, and the promising new therapies being developed through clinical research. They also share their perspectives on the future of cancer treatment and whether cancer may someday become a manageable chronic disease rather than a terminal diagnosis.Whether you're a patient, caregiver, healthcare professional, or simply interested in the latest advances in cancer care, this episode provides an informative look at the rapidly evolving world of oncology.Learn more about Noor Dermatology:https://www.noorderm.com/Timestamps00:00 – Introduction and guest introductions00:40 – Meet the medical oncologists and their backgrounds02:00 – How dermatologists and oncologists work together03:00 – When skin cancer requires advanced treatment04:00 – The multidisciplinary approach to skin cancer care06:00 – How treatment decisions are made for complex cases08:00 – Understanding advanced squamous cell carcinoma09:00 – Features that make squamous cell carcinoma high-risk10:00 – Tumor size, location, and recurrence risk11:00 – Pathology findings that influence treatment12:00 – Risk classification systems for squamous cell carcinoma14:00 – Treatment options for advanced squamous cell cancer15:00 – How immunotherapy works16:00 – Why immunotherapy changed cancer treatment forever17:00 – Organ transplant patients and skin cancer risk18:00 – Jimmy Carter, melanoma, and the impact of immunotherapy19:00 – Neoadjuvant immunotherapy and treatment before surgery20:00 – Why timing matters in melanoma treatment20:30 – Key pathology findings in melanoma22:00 – Melanoma staging and depth of invasion22:30 – What is a sentinel lymph node biopsy?24:00 – How melanoma spreads through the lymphatic system25:00 – Why sentinel lymph node biopsies matter26:00 – Benefits and limitations of lymph node evaluation27:00 – Comparing melanoma and squamous cell treatment approaches29:00 – The future of skin cancer therapies30:00 – EGFR inhibitors and emerging treatments31:00 – Injectable immunotherapy and localized treatments32:00 – Melanoma vaccines and personalized cancer treatment33:00 – New clinical trial results and cancer research34:00 – Current clinical trials at Duke35:00 – New approaches to immune therapy36:00 – Genomic sequencing and targeted therapies37:00 – BRAF mutations and precision medicine38:00 – Gene expression profiling and cancer risk assessment39:00 – Will we cure cancer in our lifetime?40:00 – Recent breakthroughs in pancreatic cancer research41:00 – Why cancer is actually hundreds of diseases42:00 – Cancer as an evolving biological opponent43:00 – The future of cancer as a chronic disease44:00 – Hope, innovation, and improving quality of life45:00 – Final thoughts and closing remarks